Langerhans Cell Histiocytosis Caused by Adalimumab for Crohn’s Disease: A Case Report
DOI:
https://doi.org/10.2340/actadv.v103.10285Keywords:
Langerhans cell histiocytosis, adalimumab, paradoxical reactionAbstract
Abstract is missing (Short communication)
Downloads
References
Windebank K, Nanduri V. Langerhans cell histiocytosis. Arch Dis Child 2009; 94: 904-908.
https://doi.org/10.1136/adc.2007.125872 DOI: https://doi.org/10.1136/adc.2007.125872
Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. N Engl J Med 2018; 379: 856-868.
https://doi.org/10.1056/NEJMra1607548 DOI: https://doi.org/10.1056/NEJMra1607548
Kobayashi M, Tojo A. Langerhans cell histiocytosis in adults: advances in pathophysiology and treatment. Cancer Science 2018; 109: 3707-3713.
https://doi.org/10.1111/cas.13817 DOI: https://doi.org/10.1111/cas.13817
Shahidi-Dadras M, Saeedi M, Shakoei S, Ayatollahi A. Langerhans cell histiocytosis: an uncommon presentation, successfully treated by thalidomide. Indian J Dermatol Venereol Leprol 2011; 77: 587-590.
https://doi.org/10.4103/0378-6323.84064 DOI: https://doi.org/10.4103/0378-6323.84064
McClain KL, Kozinetz CA. A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer 2007; 48: 44-49.
https://doi.org/10.1002/pbc.20578 DOI: https://doi.org/10.1002/pbc.20578
Seneschal J, Milpied B, Vergier B, Lepreux S, Schaeverbeke T, Taïeb A. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009; 161: 1081-1088.
https://doi.org/10.1111/j.1365-2133.2009.09329.x DOI: https://doi.org/10.1111/j.1365-2133.2009.09329.x
Rodriguez HN, García I, Alba A, Igea F. Infliximab-induced reactivated Langerhan's cell hstiocytosis in a patient with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1286-1287.
https://doi.org/10.1002/ibd.20796 DOI: https://doi.org/10.1002/ibd.20796
Podjasek JO, Loftus CG, Smyrk TC, Wieland CN. Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic. Int J Dermatol 2014; 53: 305-311.
https://doi.org/10.1111/j.1365-4632.2012.05716.x DOI: https://doi.org/10.1111/j.1365-4632.2012.05716.x
Therrien A, El Haffaf Z, Wartelle-Bladou C, Côté-Daigneault J, Nguyen BN. Langerhans cell histiocytosis presenting as Crohn's disease: a case report. Int J Colorectal Dis 2018; 33: 1501-1504.
https://doi.org/10.1007/s00384-018-3066-y DOI: https://doi.org/10.1007/s00384-018-3066-y
Kvedaraite E, Lourda M, Han H, Tesi B, Mitchell J, Ideström M et al. Patients with both Langerhans cell histiocytosis and Crohn's disease highlight a common role of interleukin-23. Acta Paediatr 2021; 110: 1315-1321.
https://doi.org/10.1111/apa.15590 DOI: https://doi.org/10.1111/apa.15590
Published
How to Cite
License
Copyright (c) 2023 Mariko Kochi, Tetsuya Higuchi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
